|By JCN Newswire||
|April 24, 2014 12:05 AM EDT||
Many developing countries throughout the world are faced with problems of Access to Medicines (ATM), which occurs when issues such as poverty and underdeveloped medical systems result in essential medicines being unable to reach the people who need them. This is especially the case with NTDs, which are a group of tropical infections that are endemic to 149 countries worldwide, primarily affecting poor people in developing and emerging countries with over 1 billion people infected. Despite most of these diseases having been treated and eliminated already in developed countries, in countries which are endemic to NTDs, patients are unable to get access to medical treatment, which is a global access to medicines issue. This is caused by a number of complex factors in endemic countries such as inadequate medical supply systems, a lack of information about diseases, and the limited adoption of disease diagnosis, prevention and treatment methods. In order to solve these issues, co-operation between governments, non-government organizations (NGOs) and pharmaceutical companies is required.
The "Eisai ATM Navigator" provides content that explains the causes, symptoms, infected regions, treatments and prevention methods for the 17 NTDs prioritized by the World Health Organization (WHO) as well as the three infectious diseases of HIV/AIDS, malaria and tuberculosis, in an easy to understand way. The website is for patients, the general public, healthcare professionals and volunteers in both developed and endemic countries. The website also introduces elimination initiatives implemented by pharmaceutical companies and other organizations.
Providing this kind of information through the website, Eisai aims to promote awareness regarding issues of Access to Medicines and NTDs among people around the world, as well as increase understanding of these diseases among people such as patients who suffer from NTDs, those at risk of infection, local healthcare professionals and volunteers, in order to help contribute toward the future elimination of NTDs.
1. About the "Eisai Access to Medicines (ATM) Navigator" Website
This is the first Japanese and English bilingual website that comprehensively provides information on topics such as NTDs, HIV/AIDS, malaria and tuberculosis, initiatives to eliminate these diseases and improve Access to Medicines for patients, the general public, healthcare professionals and volunteers in both developed and disease endemic countries. Giving consideration to the increasing usage of smartphones around the world, the website is also designed so that people in affected regions can easily view the site on smartphones as well.
The content on this website is supervised by tropical medicine researchers Dr. Tsutomu Takeuchi, Professor Emeritus and Visiting Senior Research Fellow at the Keio University Global Security Research Institute, and Dr. Hiroyoshi Endo, Professor at the Department of International Affairs and Tropical Medicine, School of Medicine, Tokyo Women's Medical University.
The main contents provided on the site are as follows:
- What is ATM: Outlines the definition of the "Access to Medicines Issue" and approaches toward improving Access to Medicines. The issue of access to medicines is that proper medicines and medical treatments are unavailable to patients in need for reasons of poverty, underdeveloped healthcare systems or other factors, particularly in the context of high-growth emerging countries and the developing world.
- About NTDs: Explains the causes, symptoms, infected regions, treatment and prevention methods of the 17 NTDs prioritized by WHO in an easy to understand way.
- Eliminating Lymphatic Filariasis: Introduces Eisai's initiatives to eliminate lymphatic filariasis. DEC (diethylcarbamazine) is one of the three drugs used to treat lymphatic filariasis and is in short supply around the world. Eisai is producing high quality DEC tablets and providing them for free to endemic countries through WHO's mass drug administration programs in order to achieve the goal of eliminating lymphatic filariasis by 2020.
- New Drug Development: Advanced countries have not been enthusiastic in developing new drugs or vaccines for the NTDs affecting developing and emerging countries because demand is low in their own countries. As a result, there are very few effective new drugs for many of these diseases even today. This section introduces examples of international collaboration in research and development which aim to create new drugs to address these needs.
- Field Reports: Presents reports by Eisai and its supporters on Access to Medicines initiatives being implemented around the world.
2. About Neglected Tropical Diseases (NTDs)
Neglected tropical diseases (NTDs) include 17 tropical diseases that the WHO (World Health Organization) identifies as diseases that the world must overcome. Prominent among them are lymphatic filariasis, Chagas' disease, and dengue fever.
NTDs are endemic in 149 countries, infecting some 1 billion people and creating serious social difficulties. Among these countries, two NTDs are endemic in 100 countries and territories, while more than six NTDs are endemic in 30 countries and territories.
Although the spread of NTDs is mainly caused by poor hygienic conditions associated with poverty, infections from these diseases may result in serious physical impairment which in turn leads to declines in the work force and productivity, thereby hampering efforts to escape from impoverished conditions. As such, the prevalence of NTDs is a stumbling block to economic growth for developing and emerging countries and represents a serious issue for these regions.
*The 17 NTDs are: Lymphatic filariasis, Chagas' disease, the leishmaniases, dracunculiasis, human African trypanosomiasis, blinding trachoma, leprosy, schistosomiasis, onchocerciasis, soil-transmitted helminthiasis, Buruli ulcer, dengue fever, cysticercosis, rabies, echinococcosis, foodborne trematodiases and endemic treponematoses
Eisai Co., Ltd. (TSE: 4523; ADR: ESALY) is a research-based human health care (hhc) company that discovers, develops and markets products throughout the world. Eisai focuses its efforts in three therapeutic areas: integrative neuroscience, including neurology and psychiatric medicines; integrative oncology, which encompasses oncotherapy and supportive-care treatments; and vascular/immunological reaction. Through a global network of research facilities, manufacturing sites and marketing subsidiaries, Eisai actively participates in all aspects of the worldwide healthcare system. For more information about Eisai Co., Ltd., please visit www.eisai.com.
Public Relations Department, Eisai Co., Ltd. +81-3-3817-5120
Copyright 2014 JCN Newswire. All rights reserved. www.japancorp.net
For organizations that have amassed large sums of software complexity, taking a microservices approach is the first step toward DevOps and continuous improvement / development. Integrating system-level analysis with microservices makes it easier to change and add functionality to applications at any time without the increase of risk. Before you start big transformation projects or a cloud migration, make sure these changes won’t take down your entire organization.
Feb. 21, 2017 07:30 PM EST Reads: 286
SYS-CON Events announced today that delaPlex will exhibit at SYS-CON's @CloudExpo, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. delaPlex pioneered Software Development as a Service (SDaaS), which provides scalable resources to build, test, and deploy software. It’s a fast and more reliable way to develop a new product or expand your in-house team.
Feb. 21, 2017 07:30 PM EST Reads: 1,130
SYS-CON Events announced today that IoT Now has been named “Media Sponsor” of SYS-CON's 20th International Cloud Expo, which will take place on June 6–8, 2017, at the Javits Center in New York City, NY. IoT Now explores the evolving opportunities and challenges facing CSPs, and it passes on some lessons learned from those who have taken the first steps in next-gen IoT services.
Feb. 21, 2017 06:30 PM EST Reads: 1,220
Updating DevOps to the latest production data slows down your development cycle. Probably it is due to slow, inefficient conventional storage and associated copy data management practices. In his session at @DevOpsSummit at 20th Cloud Expo, Dhiraj Sehgal, in Product and Solution at Tintri, will talk about DevOps and cloud-focused storage to update hundreds of child VMs (different flavors) with updates from a master VM in minutes, saving hours or even days in each development cycle. He will also...
Feb. 21, 2017 06:30 PM EST Reads: 2,375
Extreme Computing is the ability to leverage highly performant infrastructure and software to accelerate Big Data, machine learning, HPC, and Enterprise applications. High IOPS Storage, low-latency networks, in-memory databases, GPUs and other parallel accelerators are being used to achieve faster results and help businesses make better decisions. In his session at 18th Cloud Expo, Michael O'Neill, Strategic Business Development at NVIDIA, focused on some of the unique ways extreme computing is...
Feb. 21, 2017 06:30 PM EST Reads: 7,544
The explosion of new web/cloud/IoT-based applications and the data they generate are transforming our world right before our eyes. In this rush to adopt these new technologies, organizations are often ignoring fundamental questions concerning who owns the data and failing to ask for permission to conduct invasive surveillance of their customers. Organizations that are not transparent about how their systems gather data telemetry without offering shared data ownership risk product rejection, regu...
Feb. 21, 2017 06:15 PM EST Reads: 874
SYS-CON Events announced today that WineSOFT will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Based in Seoul and Irvine, WineSOFT is an innovative software house focusing on internet infrastructure solutions. The venture started as a bootstrap start-up in 2010 by focusing on making the internet faster and more powerful. WineSOFT’s knowledge is based on the expertise of TCP/IP, VPN, SSL, peer-to-peer, mob...
Feb. 21, 2017 06:15 PM EST Reads: 1,529
The Internet of Things can drive efficiency for airlines and airports. In their session at @ThingsExpo, Shyam Varan Nath, Principal Architect with GE, and Sudip Majumder, senior director of development at Oracle, discussed the technical details of the connected airline baggage and related social media solutions. These IoT applications will enhance travelers' journey experience and drive efficiency for the airlines and the airports.
Feb. 21, 2017 05:30 PM EST Reads: 1,143
With billions of sensors deployed worldwide, the amount of machine-generated data will soon exceed what our networks can handle. But consumers and businesses will expect seamless experiences and real-time responsiveness. What does this mean for IoT devices and the infrastructure that supports them? More of the data will need to be handled at - or closer to - the devices themselves.
Feb. 21, 2017 05:15 PM EST Reads: 1,745
SYS-CON Events announced today that Dataloop.IO, an innovator in cloud IT-monitoring whose products help organizations save time and money, has been named “Bronze Sponsor” of SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Dataloop.IO is an emerging software company on the cutting edge of major IT-infrastructure trends including cloud computing and microservices. The company, founded in the UK but now based in San Fran...
Feb. 21, 2017 04:30 PM EST Reads: 2,303
Big Data, cloud, analytics, contextual information, wearable tech, sensors, mobility, and WebRTC: together, these advances have created a perfect storm of technologies that are disrupting and transforming classic communications models and ecosystems. In his session at @ThingsExpo, Erik Perotti, Senior Manager of New Ventures on Plantronics’ Innovation team, provided an overview of this technological shift, including associated business and consumer communications impacts, and opportunities it m...
Feb. 21, 2017 04:00 PM EST Reads: 6,883
The financial services market is one of the most data-driven industries in the world, yet it’s bogged down by legacy CPU technologies that simply can’t keep up with the task of querying and visualizing billions of records. In his session at 20th Cloud Expo, Jared Parker, Director of Financial Services at Kinetica, will discuss how the advent of advanced in-database analytics on the GPU makes it possible to run sophisticated data science workloads on the same database that is housing the rich inf...
Feb. 21, 2017 03:30 PM EST Reads: 1,249
It is one thing to build single industrial IoT applications, but what will it take to build the Smart Cities and truly society changing applications of the future? The technology won’t be the problem, it will be the number of parties that need to work together and be aligned in their motivation to succeed. In his Day 2 Keynote at @ThingsExpo, Henrik Kenani Dahlgren, Portfolio Marketing Manager at Ericsson, discussed how to plan to cooperate, partner, and form lasting all-star teams to change the...
Feb. 21, 2017 03:15 PM EST Reads: 4,509
In his keynote at @ThingsExpo, Chris Matthieu, Director of IoT Engineering at Citrix and co-founder and CTO of Octoblu, focused on building an IoT platform and company. He provided a behind-the-scenes look at Octoblu’s platform, business, and pivots along the way (including the Citrix acquisition of Octoblu).
Feb. 21, 2017 03:15 PM EST Reads: 802
"delaPlex is a software development company. We do team-based outsourcing development," explained Mark Rivers, COO and Co-founder of delaPlex Software, in this SYS-CON.tv interview at 18th Cloud Expo, held June 7-9, 2016, at the Javits Center in New York City, NY.
Feb. 21, 2017 03:00 PM EST Reads: 5,982